Status: current, Primitive. Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3753680011 | Galcanezumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3753681010 | Galcanezumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Galcanezumab | Has disposition | Calcitonin gene-related peptide receptor antagonist | true | Inferred relationship | Some | ||
| Galcanezumab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Galcanezumab | Is a | Calcitonin gene-related peptide receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Galcanezumab only product | Has active ingredient | True | Galcanezumab | Inferred relationship | Some | 1 |
| Galcanezumab-containing product | Has active ingredient | True | Galcanezumab | Inferred relationship | Some | 1 |
| Galcanezumab-containing product in parenteral dose form | Has active ingredient | True | Galcanezumab | Inferred relationship | Some | 1 |
| Galcanezumab only product in parenteral dose form | Has active ingredient | True | Galcanezumab | Inferred relationship | Some | 1 |
| Galcanezumab 120 mg/mL solution for injection | Has precise active ingredient | True | Galcanezumab | Inferred relationship | Some | 1 |
| Galcanezumab 120 mg/mL solution for injection | Has BoSS | True | Galcanezumab | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR